Georgia's Online Cancer Information Center


back

Theragenics CEO Jacobs to Co-chair SEC committee

9/14/2011

Theragenics Corp. Chairman and CEO M. Christine Jacobs was appointed to co-chair the U.S. Securities and Exchange Commission's new advisory committee on small and emerging companies. Buford, Ga.-based Theragenics (NYSE: TGX), a surgical products and cancer treatments company, saw its profit rise about 54 percent to $1.2 million in the second quarter. Jacobs will co-chair the committee with Stephen M. Graham, partner at Fenwick & West LLP in Seattle. VIEW FULL ARTICLE

Media, News & Events

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
About Us Research Resources & Education Screening & Genetics Clinical Trials & Providers Cancer Navigators Survivorship Media, News & Events Contact Us Donate Take Our Survey Link to Us

Research

Screening & Genetics

Clinical Trials & Providers

Survivorship

About Georgia CORE

Education & Resources

Media, News & Events

Patient Navigation

Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.